Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Identification of recombinant strains in HCV genotype 1 and 3: Is it needed?

Zarkua J, Zakalashvili M, Gish RG, Metreveli D.

Liver Int. 2018 Feb 26. doi: 10.1111/liv.13729. [Epub ahead of print] No abstract available.

PMID:
29479791
2.

Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.

Zakalashvili M, Zarkua J, Weizenegger M, Bartel J, Raabe M, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Hedskog C, Chodavarapu K, Brainard DM, McHutchison JG, Mo H, Svarovskaia E, Gish RG, Rtskhiladze I, Metreveli D.

Liver Int. 2018 Mar;38(3):451-457. doi: 10.1111/liv.13540. Epub 2017 Sep 2.

PMID:
28782185
3.

The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.

Nasrullah M, Sergeenko D, Gvinjilia L, Gamkrelidze A, Tsertsvadze T, Butsashvili M, Metreveli D, Sharvadze L, Alkhazashvili M, Shadaker S, Ward JW, Morgan J, Averhoff F.

MMWR Morb Mortal Wkly Rep. 2017 Jul 28;66(29):773-776. doi: 10.15585/mmwr.mm6629a2.

4.

PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PREDICTORS OF THE EFFECTIVENESS OF PEGYLATED INTERFERON IN PATIENTS WITH HEPATITIS C IN GEORGIA.

Tsertsvadze T, Sharvadze L, Metreveli D, Ruadze E.

Georgian Med News. 2017 Apr;(265):30-40.

PMID:
28577015
5.

Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.

Zakalashvili M, Weizenegger M, Bartel J, Markowski M, Zarqua J, Kavsadze S, Kvatadze K, Basheleishvili G, Phirtskhalaishvili T, Dzagania T, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Rtskhiladze I, Metreveli D.

Clin Lab. 2016 Jul 1;62(7):1347-1351. doi: 10.7754/Clin.Lab.2016.151210.

PMID:
28164650
6.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators.

N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.

7.

One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.

Schwarz HP, Birkholz-Walerzak D, Szalecki M, Walczak M, Galesanu C, Metreveli D, Khan-Boluki J, Schuck E.

Biol Ther. 2014 Dec;4(1-2):1-13. doi: 10.1007/s13554-014-0014-4. Epub 2014 Jan 28.

8.

Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.

Kikodze N, Pantsulaia I, Rekhviashvili Kh, Iobadze M, Dzhakhutashvili N, Pantsulaia N, Kukuladze N, Bikashvili N, Metreveli D, Chikovani T.

Georgian Med News. 2013 Sep;(222):29-35.

PMID:
24099812
9.

[Microbial structure of acute bacterial conjunctivitis].

Chikviladze D, Nikuradze N, Gachechiladze Kh, Miqeladze M, Metreveli D.

Georgian Med News. 2013 Mar;(216):12-5. Russian.

PMID:
23567301
10.

[Antibiotic resistance of nosocomial strains of Staphylococcus spicies].

Chikviladze DP, Metreveli DA, Gachechiladze KhE, Mikeladze ML.

Georgian Med News. 2012 Jan;(202):60-3. Russian.

PMID:
22392785
11.

[Microbial spectrum of nosocomial pneumonia in traumatological patients].

Avazashvili N, Nozadze T, Chikviladze D, Gachechiladze Kh, Metreveli D, Mikeladze M.

Georgian Med News. 2011 May;(194):76-9. Russian.

PMID:
21685529
12.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group.

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12.

PMID:
21225239
13.

[Microbiological investigation of diabetic foot infections].

Chikviladze D, Gachechiladze Kh, Mikeladze M, Metreveli D, Avazashvili D.

Georgian Med News. 2010 Jun;(183):22-6. Russian.

PMID:
20622271
14.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.

15.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.

PMID:
18823656
16.

Local blood flow in the dorsal hippocampus and cerebellar cortex in the offspring of iodine-deficient rats.

Gabrichidze GO, Lazrishvili NI, Metreveli DS, Bekaya GL, Mitagvariya NP.

Neurosci Behav Physiol. 2007 Jun;37(5):495-8.

PMID:
17505801
17.

The hearing system under thyroid hypofunction.

Khechinaschvili S, Metreveli D, Svanidze N, Knothe J, Kevanishvili Z.

Georgian Med News. 2007 Mar;(144):30-3.

PMID:
17473330
18.

Growth hormone (GH) determinations by RIA and IFA during GH stimulation tests in children with short stature.

Kvaratskhelia E, Metreveli D, Koplatadze K, Virsaladze D, Willig R.

Georgian Med News. 2006 Nov;(140):51-4.

PMID:
17179589
19.

[About correlation of dysfunction of the thyroid gland with fibrocystic diseases in women].

Mardaleishvili KG, Nemsadze GG, Metreveli DS, Roinishvili TL.

Georgian Med News. 2006 Nov;(140):30-2. Russian.

PMID:
17179583
20.

[Local blood flow in the dorsal hippocampus and cerebellar cortex in progeny of iodine-deficient rats].

Gabrichidze GO, Lazrishvili NI, Metreveli DS, Bekaia GL, Mitagvariia NP.

Ross Fiziol Zh Im I M Sechenova. 2006 Mar;92(3):292-8. Russian.

PMID:
16739638

Supplemental Content

Loading ...
Support Center